Assembly Biosciences, Inc. Increase (Decrease) in Other Noncurrent Assets
Assembly Biosciences, Inc. (ASMB) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2025-03-20
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was $0.00.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-06-30 was $0.00.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-03-31 was $0.00.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$577.00K.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$814.00K.
- Assembly Biosciences, Inc. increase (decrease) in other noncurrent assets for fiscal 2021 was -$4.69M, a 199.60% decline from fiscal 2020.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | -$240.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$240.00K derived: sum of 3 quarters · filed 2025-03-20 | -$20.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | -$240.00K derived: sum of 2 quarters · filed 2025-03-20 | -$20.00K derived: sum of 3 quarters · filed 2025-03-20 | -$22.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-12-31 | -$240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$20.00K derived: sum of 2 quarters · filed 2025-03-20 | -$22.00K derived: sum of 3 quarters · filed 2025-03-20 | -$577.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $218.00K derived: sum of 2 quarters · filed 2024-11-07 | -$337.00K 10-Q · filed 2024-11-07 | -$1.06M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$557.00K 10-Q · filed 2024-08-08 | -$1.28M derived: sum of 3 quarters · filed 2024-08-08 | -$1.30M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$555.00K 10-Q · filed 2024-05-08 | -$1.28M derived: sum of 2 quarters · filed 2024-05-08 | -$1.30M derived: sum of 3 quarters · filed 2024-05-08 | -$1.84M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$746.00K derived: sum of 2 quarters · filed 2024-03-28 | -$1.29M derived: sum of 3 quarters · filed 2024-03-28 | -$814.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$562.00K derived: sum of 2 quarters · filed 2023-11-08 | -$90.00K 10-Q · filed 2023-11-08 | -$309.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$540.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$68.00K 10-Q · filed 2023-08-09 | -$287.00K derived: sum of 3 quarters · filed 2023-08-09 | -$4.46M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $472.00K 10-Q · filed 2023-05-04 | $253.00K derived: sum of 2 quarters · filed 2023-05-04 | -$3.92M derived: sum of 3 quarters · filed 2023-05-04 | -$3.86M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$4.39M derived: sum of 2 quarters · filed 2023-03-22 | -$4.33M derived: sum of 3 quarters · filed 2023-03-22 | -$4.69M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$4.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$4.11M derived: sum of 2 quarters · filed 2022-11-08 | -$4.47M 10-Q · filed 2022-11-08 | -$4.06M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$299.00K 10-Q · filed 2022-08-09 | $113.00K derived: sum of 3 quarters · filed 2022-08-09 | $2.25M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$358.00K 10-Q · filed 2022-05-12 | $54.00K derived: sum of 2 quarters · filed 2022-05-12 | $2.19M derived: sum of 3 quarters · filed 2022-05-12 | $4.37M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.55M derived: sum of 2 quarters · filed 2022-03-11 | $4.73M derived: sum of 3 quarters · filed 2022-03-11 | $4.71M 10-K · filed 2022-03-11 |
| 2020-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.32M derived: sum of 2 quarters · filed 2021-11-04 | $4.30M 10-Q · filed 2021-11-04 | $4.31M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.15M 10-Q · filed 2021-08-05 | $2.17M derived: sum of 3 quarters · filed 2021-08-05 | $2.15M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$23.00K 10-Q · filed 2021-05-06 | -$10.00K derived: sum of 2 quarters · filed 2021-05-06 | -$32.00K derived: sum of 3 quarters · filed 2021-05-06 | $0.00 derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$9.00K derived: sum of 2 quarters · filed 2021-02-25 | $23.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.66M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.00K derived: sum of 2 quarters · filed 2020-11-05 | -$1.68M 10-Q · filed 2020-11-05 | $720.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$1.66M 10-Q · filed 2020-08-05 | $742.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.35M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$1.69M 10-Q · filed 2020-05-08 | $710.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.32M derived: sum of 3 quarters · filed 2021-02-25 | $1.32M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.01M derived: sum of 2 quarters · filed 2021-02-25 | $3.01M derived: sum of 3 quarters · filed 2021-02-25 | $3.01M 10-K · filed 2021-02-25 |
| 2018-09-30 | $611.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $611.00K derived: sum of 2 quarters · filed 2019-11-07 | $611.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $84.00K 10-K · filed 2020-03-04 | |||
| 2016-12-31 | $58.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |